Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
Elke Jäger(Krankenhaus Nordwest), Alexander Knuth(National Center for Cancer Care and Research), Yao‐Tseng Chen(Memorial Sloan Kettering Cancer Center), P. Rod Dunbar(Memorial Sloan Kettering Cancer Center), Hisashi Wada(The University of Osaka), Michael Arand(University of Zurich), Gerd Ritter(Memorial Sloan Kettering Cancer Center), Elisabeth Stockert(Memorial Sloan Kettering Cancer Center), Sacha Gnjatic(Tisch Hospital), Bo Dupont(Memorial Sloan Kettering Cancer Center), Lloyd J. Old(Gynecologic Oncology Group), Julia Karbach(Memorial Sloan Kettering Cancer Center), Sang Yull Lee(Memorial Sloan Kettering Cancer Center), Yasuhiro Nagata(Memorial Sloan Kettering Cancer Center), Vincenzo Cerundolo(John Radcliffe Hospital), Dirk Jäger(Memorial Sloan Kettering Cancer Center), Achim A. Jungbluth(Gynecologic Oncology Group)
Cited by 398
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k